State Key Laboratory of Food Science and Technology, College of Life Sciences and Food Engineering, Nanchang University, Nanchang 330047, China.
Biochem Biophys Res Commun. 2013 Oct 4;439(4):493-500. doi: 10.1016/j.bbrc.2013.08.096. Epub 2013 Sep 8.
Fragile X syndrome, one of the most common forms of inherited mental retardation, is caused by expansion of the CGG repeat in the 5'-untranslated region of the X-linked Fmr1 gene, which results in transcriptional silencing and loss of expression of its encoded protein FMRP. The loss of FMRP increases proliferation and alters fate specification in adult neural progenitor cells (aNPCs). However, little is known about Fmr1 mRNA regulation at the transcriptional and post-transcriptional levels. In the present study, we report that miR-130b regulated Fmr1 expression by directly targeting its 3'-untranslated region (3' UTR). Up-regulation of miR-130b in mouse embryonic neural progenitor cells (eNPCs) decreased Fmr1 expression, markedly increased eNPC proliferation and altered the differentiation tendency of eNPCs, suggesting that antagonizing miR-130b may be a new therapeutic entry point for treating Fragile X syndrome.
脆性 X 综合征是最常见的遗传性智力障碍之一,它是由 X 连锁的 Fmr1 基因 5'非翻译区的 CGG 重复扩展引起的,导致转录沉默和其编码的蛋白 FMRP 表达丧失。FMRP 的缺失增加了成年神经祖细胞 (aNPCs) 的增殖并改变了其命运特化。然而,关于 Fmr1 mRNA 在转录和转录后水平的调节知之甚少。在本研究中,我们报告说 miR-130b 通过直接靶向其 3'非翻译区 (3'UTR) 来调节 Fmr1 的表达。在小鼠胚胎神经祖细胞 (eNPCs) 中上调 miR-130b 会降低 Fmr1 的表达,显著增加 eNPC 的增殖并改变 eNPC 的分化趋势,表明拮抗 miR-130b 可能是治疗脆性 X 综合征的新治疗切入点。